Drug
ustekinumab-srlf
Marketed as IMULDOSA.
Generic name
ustekinumab-srlf
Brand names
IMULDOSA
First FDA approval
2024-10-10
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761364 | IMULDOSA | 2024-10-10 | ACCORD BIOPHARMA INC. |
Manufacturers
ACCORD BIOPHARMA INC.
Frequently asked questions
When was ustekinumab-srlf FDA approved?
Earliest FDA approval on record: 2024-10-10.
What brand names are sold as ustekinumab-srlf?
IMULDOSA.
Sources
Appeal a ustekinumab-srlf denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com